Skip to content
News
Anal Cancer
Bladder Cancer
Bone Cancer
Brain Cancer
Breast Cancer
Cancer of Unknown Primary
Cervical Cancer
Colon Cancer
Esophageal Cancer
Gastric Cancer
GIST
Head & Neck Cancer
Hodgkins Lymphoma
Leukemia
Acute Leukemia
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Liver Cancer
Lung Cancer
Melanoma
Mesothelioma
Multiple Myeloma
Myelodysplastic Syndrome
MPN-PV-ET-MF
Neuroblastoma
Neuroendocrine Tumors
Non Hodgkins Lymphoma
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Renal Cancer
Rectal Cancer
Sarcoma
Skin Care
Skin Cancer
Testicular Cancer
Thyroid Cancer
Triple Negative Breast Cancer
Uterine Cancer
About Us
Advertising
News
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
Search
Thyroid Cancer
July 12, 2018
Nexavar Shows Promise Against Aggressive Thyroid Cancers
Dr. C H Weaver MD
July 12, 2018
Thyroid Ultrasound May Cut Biopsy Rate
Dr. C H Weaver MD
July 11, 2018
Selumetinib May Reverse Radioiodine Resistance in Advanced Thyroid Cancer
Dr. C H Weaver MD
July 11, 2018
Mutations Linked to Drug Response in Medullary Thyroid Cancer
Dr. C H Weaver MD
July 5, 2018
Low-Dose Radioiodine Effective in Thyroid Cancer
Dr. C H Weaver MD
July 5, 2018
Targeted Drug Caprelsa Slows Thyroid Cancer
Dr. C H Weaver MD
July 4, 2018
Risk of Thyroid Cancer Remains Elevated Among Survivors of Hiroshima & Nagasaki
Dr. C H Weaver MD
July 1, 2018
Cabozantinib Shows Benefit in Medullary Thyroid Cancer
Dr. C H Weaver MD
July 1, 2018
Zactima Active Against Hereditary Medullary Thyroid Cancer
Dr. C H Weaver MD
July 1, 2018
Votrient Promising in Advanced Differentiated Thyroid Cancer
Dr. C H Weaver MD
July 1, 2018
Tromethamine in Addition to Chemotherapy may Improve Survival in Thyroid Cancer
Dr. C H Weaver MD
July 1, 2018
Vandetanib Approved for Medullary Thyroid Cancer
Dr. C H Weaver MD
Previous Page
1
2
3
4
5
Next Page
Loading Comments...
Write a Comment...
Email (Required)
Name (Required)
Website
